NASDAQ
BioNexus Gene Lab Corp. (BGLC) has a current ratio of 10.46x as of Monday, May 25, 2026. This represents a 182.91% increase compared to its 12-month average of 3.70x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.